Safety, Tolerability and PK Study of Single Doses of ABT-450 With and Without Ritonavir to Treat Hepatitis C Virus (HCV) Genotype 1
Clinical trial NCT00850044 · COMPLETED
Trial details
- NCT number
- NCT00850044
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2009-07-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.